Clinical Trial Update: 2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating 2-Hydroxybenzylamine (2-HOBA) to reduce HDL modification and improve HDL function in familial hypercholesterolemia, current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia

Drugs mentioned

• 2-Hydroxybenzylamine (2-HOBA) (2-Hydroxybenzylamine)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Familial Hypercholesterolemia | Phase 2 | Status: RECRUITING